Bio Pharma Dive

JUNE 26, 2023

By the end of September, the FDA will hold two anticipated advisory meetings and issue important decisions on drugs for Alzheimer’s, depression and a type of vision loss.

Drugs 273

Drugs 273

Pharmaceutical Technology

JUNE 26, 2023

After Intercept’s Ocaliva rejection, multiple companies are taking aim at becoming the first US-approved NASH therapy.

Drugs 321

Drugs 321

AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 26, 2023

“Cassie” is an anxious adult. She stresses and puts off tasks that should be simple. Seeing others succeed makes her feel inadequate. It’s easier to avoid challenges than risk failing again. She has taken anxiety medication, but it didn’t help much. This hypothetical example illustrates a situation many people have faced.

Clinical Trials 203

Clinical Trials Clinical Trials Trials 203

Bio Pharma Dive

JUNE 26, 2023

Liver enzyme elevations in early- and mid-stage testing have led the drugmaker to discontinue development of lotiglipron and focus on another prospect that’s shown early promise.

Development 164

Development 164

Advertisement

Clinical Supply

AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 26, 2023

In order to encourage the sustainable quality in healthcare and patient safety, innovative ideas and implemented practices, the National Accreditation Board for Hospitals and Healthcare Providers (NABH) launched a platform named “NABH Best practices Club” where the NABH accredited/ certified/ applicant hospitals can present and pitch their best practices in their organizations.

Clinical Trials 146

Clinical Trials Clinical Trials Clinical Research Trials 146

Bio Pharma Dive

JUNE 26, 2023

Susan Langer, whose nomination stirred controversy due to her ties to an outgoing director, will now join seven other board members who successfully ran for re-election.

139

139

Bio Pharma Dive

JUNE 26, 2023

The biotech is planning a “significant cost reduction” effort in the U.S. following a Phase 3 failure in idiopathic pulmonary fibrosis, the third trial miss it’s reported since May.

Trials 130

Trials 130

Rethinking Clinical Trials

JUNE 26, 2023

Eliseo J. Pérez-Stable, MD This year’s annual Steering Committee meeting for the NIH Pragmatic Trials Collaboratory featured health equity as a central topic of discussion. In an interview after his keynote presentation, Eliseo J. Pérez-Stable, MD, Director of the National Institute on Minority Health and Health Disparities (NIMHD), shared his thoughts on national priorities for reducing health disparities and opportunities for clinical researchers to help promote health equity.

Research 130

Research Big Data Clinical Research Trials 130

Pharmaceutical Technology

JUNE 26, 2023

Managing data privacy and security is essential for the future digitalisation of healthcare. We explore how the sector can adapt to embrace smart medical technologies while preserving patient data confidentiality.

130

130

Bio Pharma Dive

JUNE 26, 2023

Chromatographic resins are important in the development of antibody therapeutics.

Antibody 139

Antibody Development 139

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharmaceutical Technology

JUNE 26, 2023

Lipid nanoparticles are enabling a new generation of engineered cell therapies with a push towards more complex cell engineering and gene editing for allogeneic therapies

Gene Editing 130

Gene Editing Gene Engineer 130

Antidote

JUNE 26, 2023

Every June is designated as Alzheimer’s and Brain Awareness Month , a month dedicated to raising awareness for Alzheimer’s disease and other types of dementias. Alzheimer’s disease is the most common type of dementia , and has impacted humans long before it was officially named in 1910.

98

98

Pharmaceutical Technology

JUNE 26, 2023

Shionogi has signed a definitive agreement for the acquisition of Qpex Biopharma in a deal valued at approximately $140m.

147

147

XTalks

JUNE 26, 2023

By strategically leveraging content, businesses can drive revenue growth and achieve their financial objectives. Content marketing not only builds trust and credibility but also helps in driving brand awareness which attracts potential customers. Life science companies can position themselves as authoritative sources, create a community of loyal followers and influence purchasing decisions by leveraging content marketing strategies.

Life Science 98

Life Science Marketing Sales Production 98

Advertisement

Clinical Supply

Pharmaceutical Technology

JUNE 26, 2023

The company will continue with danuglipron as the competition against Novo Nordisk and Eli Lilly for an oral weight-loss drug intensifies.

Drugs 130

Drugs 130

XTalks

JUNE 26, 2023

The processing of fish feces can enable self-sustaining fish and vegetable farms (known as aquaponics) to generate biogas. This biogas can then be reintegrated into the farm’s energy system, contributing to its overall sustainability. Recent groundbreaking research conducted at the University of Gothenburg highlights the remarkable potential of utilizing fish feces for both energy production and plant nourishment.

Production 98

Production Engineer Doctors Doctor 98

Pharmaceutical Technology

JUNE 26, 2023

The FDA has approved Pfizer’s Litfulo for treating young patients with severe alopecia areata, the first available treatment of its kind.

FDA Approval 130

FDA Approval 130

Fierce Pharma

JUNE 26, 2023

The FDA's review teams were moving against an approval of Sarepta's Duchenne muscular dystrophy gene therapy. | The FDA's review teams were moving against an approval of Sarepta's Duchenne muscular dystrophy gene therapy. But Peter Marks, director of the agency's Center for Biologics Evaluation and Research, disagreed with the staffers' interpretations, coming to a "different conclusion" that led to an eventual approval, a memo shows.

Gene Therapy 98

Gene Therapy Gene Research 98

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Pharmaceutical Technology

JUNE 26, 2023

Boehringer and Zealand released Phase II data with the investigational drug survodutide, while Novo Nordisk presented new Ozempic data.

Marketing 130

Marketing Drugs 130

XTalks

JUNE 26, 2023

Medical device and in vitro diagnostics technologies provider SurModic Inc. has announced that its new drug-coated balloon (DCB) SurVeil has been granted approval by the US Food and Drug Administration (FDA). The balloon is designed for the treatment of patients with peripheral artery disease. The approval comes after the FDA made several requests for additional data, which lengthened the approval process that began in 2021.

FDA Approval 96

FDA Approval Drugs Sales In-Vitro 96

Pharmaceutical Technology

JUNE 26, 2023

CMP Pharma has announced the availability of Atorvaliq for treating high cholesterol and specific heart disease or stroke risk factors.

130

130

Fierce Pharma

JUNE 26, 2023

Lundbeck CEO Deborah Dunsire is stepping down on a high note in the neuroscience company’s history. | Lundbeck CEO Deborah Dunsire is retiring on a high note in the neuroscience company’s history. After hitting the company's highest quarterly revenue in the first quarter, the five-year Lundbeck chief executive will pass the baton to UCB's neurology head.

Sales 94

Sales 94

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Pharmaceutical Technology

JUNE 26, 2023

Gilead Sciences has received positive opinion from the EMA's CHMP for its Trodelvy (sacituzumab govitecan) to treat breast cancer.

130

130

BioSpace

JUNE 26, 2023

Patients treated in a Phase II study with Lilly’s retatrutide saw up to 24% weight loss at 48 weeks, driven by a triagonist mode of action that can bind and activate the GLP-1, GIP and glucagon receptors.

Drugs 94

Drugs 94

Pharmaceutical Technology

JUNE 26, 2023

The UK government has announced a lung cancer screening programme to aid in identifying cancer earlier and expedite its diagnosis.

130

130

Fierce Pharma

JUNE 26, 2023

The potential advantages of a daily-pill version of popular GLP-1 drugs for Type 2 diabetes and obesity are obvious compared to the weekly-injection routine most patients taking these drugs undergo | The potential advantages of a daily-pill version of popular GLP-1 drugs for Type 2 diabetes and obesity are obvious compared to the weekly-injection routine most patients taking these drugs undergo.

Drugs 90

Drugs Marketing 90

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Pharmaceutical Technology

JUNE 26, 2023

iNova Pharmaceuticals has entered a deal to acquire a consumer healthcare brand portfolio from Mundipharma International.

Branding 130

Branding 130

Cloudbyz

JUNE 26, 2023

Generative artificial intelligence (AI) techniques are increasingly being applied in clinical research to enhance various aspects of medical data analysis, diagnosis, treatment planning, and drug discovery. By leveraging the power of generative models, researchers can generate synthetic data, simulate biological processes, optimize treatment strategies, and facilitate the development of novel therapeutics.

Clinical Research 89

Clinical Research Research Clinical Trials Clinical Trials 89

Pharma Times

JUNE 26, 2023

The authorisation would include certain patients with refractory generalised myasthenia gravis - News - PharmaTimes

Marketing 104

Marketing 104

BioSpace

JUNE 26, 2023

Phase II results of MoonLake’s sonelokimab suggest superiority to the competition. Funds raised in the stock offering will support Phase III trials with an anticipated launch in 2027.

Trials 87

Trials 87

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Clinical Supply